289 related articles for article (PubMed ID: 16565388)
1. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388
[TBL] [Abstract][Full Text] [Related]
2. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
3. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
Hori J; Joyce NC; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
[TBL] [Abstract][Full Text] [Related]
4. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
[TBL] [Abstract][Full Text] [Related]
5. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
6. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
[TBL] [Abstract][Full Text] [Related]
7. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
Wenkel H; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
Ishioka M; Okamoto S; Streilein JW; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
11. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
Jiang LQ; Streilein JW
Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
[TBL] [Abstract][Full Text] [Related]
12. Immunological characteristics of amniotic epithelium.
Hori J; Wang M; Kamiya K; Takahashi H; Sakuragawa N
Cornea; 2006 Dec; 25(10 Suppl 1):S53-8. PubMed ID: 17001194
[TBL] [Abstract][Full Text] [Related]
13. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290
[TBL] [Abstract][Full Text] [Related]
14. Anterior chamber-associated immune deviation promotes corneal allograft survival.
Niederkorn JY; Mellon J
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
[TBL] [Abstract][Full Text] [Related]
15. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
16. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
Osawa H; Maruyama K; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
[TBL] [Abstract][Full Text] [Related]
17. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori J; Joyce N; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
[TBL] [Abstract][Full Text] [Related]
18. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
[TBL] [Abstract][Full Text] [Related]
19. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts.
Jiang LQ; Jorquera M; Streilein JW
Exp Eye Res; 1994 Jun; 58(6):719-28. PubMed ID: 7925711
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice.
Hori J; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1820-8. PubMed ID: 11431448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
